Latest News - Boston Scientific

Top Corporates Hub

Boston Scientific

BSX | NYSE | United States
101
+33
Rank
$112.32B
Market Cap
$16.74B
+$ 2.5B
+17.56%
Revenue
$2.28B
+$ 0.3B
+15.15%
Earnings
53K
+5K
+10.42%
Employees
5 Insightful Analyst Questions From Boston Scientific’s Q3 Earnings Call

29.10.2025 05:35

Boston Scientific’s third quarter saw a positive market reaction, reflecting operational execution across multiple business units. Management attributed the strong results to broad-based growth, especially in electrophysiology and the WATCHMAN left atrial appendage closure device, which CEO Michael Mahoney called “a gem for Boston Scientific.” The company also noted resilient demand in the U.S. and Asia Pacific, with double-digit growth in Japan and China. Mahoney emphasized that growth was driv

Read More

Is Boston Scientific’s Rally Justified After Another Year of Double Digit Gains?

29.10.2025 01:11

If you are trying to figure out what to do with Boston Scientific stock right now, you are not alone. It is one of those names that investors keep coming back to, especially after a remarkable run in recent years. Just think about it: the stock has climbed an impressive 19.4% in the past year and a staggering 187.3% over five years. Even more, the year-to-date gain of 13.0% and a steady 2.8% in the last 30 days suggest this momentum may have staying power. Behind these moves is a string of...

Read More

United States Nebulizer Market Research 2025-2033, Competitive Analysis of OMRON, GE Healthcare, Boston Scientific, Koninklijke Philips, Vectura, Aerogen, DeVilbiss Healthcare, Beurer

27.10.2025 15:48

The United States nebulizer market is set to grow from US$ 466.55 million in 2024 to US$ 730.62 million by 2033, with a CAGR of 5.11%. This growth is driven by the rising prevalence of respiratory diseases, advancements in nebulizer technology, and an increased focus on home healthcare solutions. Nebulizers offer effective inhalation therapy for conditions like asthma, COPD, and cystic fibrosis. Technological improvements such as smart connectivity and portable designs enhance user convenience,

Read More

PAHC vs. BSX: Which Stock Is the Better Value Option?

27.10.2025 15:40

PAHC vs. BSX: Which Stock Is the Better Value Option?

Read More

RVTY Q3 Earnings Beat, Sales In Line, '25 EPS View Raised

27.10.2025 14:05

Revvity beats on Q3 earnings and raises 2025 EPS view, as balanced segment performance offsets margin pressure.

Read More

Does Boston Scientific (BSX) Have the Potential to Rally 25.61% as Wall Street Analysts Expect?

27.10.2025 13:55

The consensus price target hints at a 25.6% upside potential for Boston Scientific (BSX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Read More

Does GEHC Stock Deserve a Spot in Your Portfolio Ahead of Q3 Earnings?

27.10.2025 13:20

GE HealthCare's Q3 results are expected to show steady growth from Imaging and Diagnostics, though tariffs may weigh on margins and EPS.

Read More

Boston Scientific: Continuing Its M&A Playbook, As Organic Achievements Impress

24.10.2025 10:11

Boston Scientific shows strong organic growth, margin expansion, and strategic acquisitions, trading at a premium with long-term potential. See why BSX stock is a hold.

Read More

Boston Scientific Corporation 2025 Q3 - Results - Earnings Call Presentation

22.10.2025 08:49

2025-10-22. The following slide deck was published by Boston Scientific Corporation in conjunction with their 2025 Q3 earnings call.

Read More

HIMS Stock Declines Despite Launch of New Specialty in Women's Health

21.10.2025 14:06

Hims & Hers debuts a new women's health specialty, targeting menopause care with personalized treatment plans.

Read More

Analyst Visit Confirms Growth Potential for Boston Scientific Corporation (BSX), Buy Rating Retained

21.10.2025 10:33

Boston Scientific Corporation (NYSE:BSX) ranks among the best medical device stocks to invest in. Following an analyst visit to Boston Scientific Corporation (NYSE:BSX)’s headquarters, TD Cowen reaffirmed its Buy rating and $115 price target on the company on October 10. According to the firm, the visit strengthened its belief in Boston Scientific’s outlook, which it […]

Read More

Boston Scientific (BSX) Reports Q3: Everything You Need To Know Ahead Of Earnings

21.10.2025 03:08

Medical device company Boston Scientific (NYSE:BSX) will be announcing earnings results this Wednesday morning. Here’s what to expect.

Read More

4 Top AI-Powered Healthcare Stocks

09.10.2025 05:00

Healthcare stocks are up despite a government shutdown as AI transforms drug discovery, diagnostics, and robotics. Click here for top AI healthcare stocks.

Read More

Boston Scientific: Not In The Most Resolute State As It Approaches Q3 Earnings

09.10.2025 04:13

Read here for Boston Scientific (BSX) stock's outlook ahead of Q3 earnings, assess valuation, margin pressures, and acquisition impacts.

Read More

Abbott Laboratories Still Offers Attractive Valuation, UBS Says

08.10.2025 18:14

Abbott Laboratories' (ABT) diabetes, electrophysiology, and structural heart businesses' growth outl

Read More

RBC Capital Maintains a Buy on Boston Scientific Corporation (BSX) With a $125 PT

03.10.2025 10:27

Boston Scientific Corporation (NYSE:BSX) is one of the best medical stocks to buy now. On September 29, RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Boston Scientific Corporation (NYSE:BSX) and set a price target of $125.00. Boston Scientific Corporation (NYSE:BSX) reported in its fiscal Q2 2025 earnings that net sales for the […]

Read More